It can be accessed through the following link: . Dr. Daveson stated, "Celiac disease affects approximately 1.4% of the world's population. The only current treatment option is a strict, lifelong ...
A new group, featuring health workers, first responders, labour figures and a pharmaceutical company, is behind the latest request to the province to work on an opioid treatment plan, which they hope ...
Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments. One of these, lecanemab ...